Navigation Links
EchoScan US-3300

ProductsEchoScan US-3300
Company NIDEK, Inc.
Item EchoScan US-3300
Features 
  • Versatile A/B scan.
  • Post-processing function.
  • User friendly operation.
  • US-3300 can be integrated with Nidek Advanced Vision Information
  • System (NAVIS) for practical data management.
Description EchoScan US-3300 takes accurate axial length and corneal thickness measurements in either automatic or manual modes. It is available in a single configuration or in combination with the A scan for maximum cost efficiency.
Info NIDEK, Inc.
Customer Service: 1-800-223-9044
Web site: http://www.usa.nidek.com

Related medicine products :

1. EchoScan US-1800, Pachymeter and A-scan
2. EchoScan US-2500
3. EchoScan US-1800
4. EchoScan US-800
... Since 1991 Intersurgical ... breathing filters, heat and ... oxygen therapy products, hand-held ... range of accessories and ...
... Ulti-Mist™ HME product line has the right ... to adults and from intubated patients to ... humidification for both anesthesia and critical care ... provide maximum protection for patients and staff ...
... These hygroscopic condenser humidifiers (HCH) capture ... return them in the inspired gas. Small ... provide bacteriostatic and hygroscopic benefits. Depending on ... adult or small-volume model., ,The adult ...
... capture the patient`s exhaled heat and moisture ... Small and compact, they are specially treated ... on the tidal volume requirements, select either ... adult HCH is ideal for patient tidal ...
Medicine Products:
(Date:3/28/2015)... 2015 An article in Fortune on ... prove critical to organizations that deal with PCI (Payment ... of data security, is worsening . Using numbers ... every major category out of the twelve measured improved, ... all the craziness that has gone on in the ...
(Date:3/28/2015)... How best to treat and recover from ... medicine. While diagnostic hip injections are commonly performed for ... research presented today at the American Orthopaedic Society for ... pain relief from this diagnostic injection may not predict ... study looked to assess if the amount of pain ...
(Date:3/28/2015)... San Francisco, California (PRWEB) March 28, 2015 ... search for original 1960's Who psychedelic concert posters. The Who ... Flushing, New York on August 2, 1968. According to Hawley, ... 1969 playing many concert halls and college campuses. Perhaps the ... their performance with Jim Morrison and the Doors on August ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 The ... method of sustainable health. After 18 years of research ... including professional UFC contenders, Dr. Jon Petrick is excited ... , Just some of the immediate benefits of this ... vitality, increased levels of strength of the immune system, ...
(Date:3/28/2015)... March 28, 2015 Servpro of ... this week released a report about the link between ... asthma sufferers, and according to recent medical research, may ... According to the Environmental Protection Agency, people with sensitivity ... Breathing in mold may trigger asthma attacks for asthma ...
Breaking Medicine News(10 mins):Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 3Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 4Health News:Pain Injections for Hip Arthroscopy Patients May Not Predict Surgical Outcomes 2Health News:Avid Collector from Vintage Rock Posters, Inc. Announces His Search For Original 1960's Who Psychedelic Concert Posters. 2Health News:Celebrity Chiropractor Jon Petrick to Release Sustainable Health System this Summer 2Health News:Water Damage Restoration Specialists Servpro of Paso Robles Release Report on Mold and Asthma 2Health News:Water Damage Restoration Specialists Servpro of Paso Robles Release Report on Mold and Asthma 3
... Now an Arizona cosmetic surgeon performs a unique procedure to harvest fat ... help women obtain shapely bodies. , ... Phoenix, AZ (PRWEB) November 6, ... to create a body you,ll love? , , ,Dr. Edgardo Zavala, a ...
... in Malibu, recently celebrated its fourth anniversary with a slew of ... current and past residents. , ... (PRWEB) November 6, ... in Malibu, recently celebrated its fourth anniversary with a slew of ...
... at least some comfort in a recent, first-of-its-kind study that ... significantly lower risk of breast cancer. Christopher I. Li, M.D., ... these findings in the November issue of Cancer Epidemiology, ... who had a history of migraines had a 30 percent ...
... age and race are among the factors that can ... after carotid-artery surgery, a UT Southwestern physician involved in ... identified 11 readily available, clinical risk factors that can ... the risks and benefits of carotid surgery for an ...
... The Global AIDS Alliance,today welcomed the election of ... "We look forward to working with President-elect Obama as ... over 5,000 people and,infects another 7,500 every day," said ... "As Colin Powell, Robert Rubin and others have recently ...
... million, Earnings per Diluted, Share of $0.32 and Contract Value of $230.6 million; ... ... 5 The Advisory Board Company,(Nasdaq: ABCO ) today announced financial results ... the quarter increased 7%,to $57.6 million, from $54.0 million in the second quarter ...
Cached Medicine News:Health News:Unsightly Fat Beautifies Body 2Health News:Unsightly Fat Beautifies Body 3Health News:Malibu Alcohol and Drug Rehab Center Celebrates Fourth Anniversary 2Health News:Migraines associated with lower risk of breast cancer 2Health News:Age, race are among factors that influence carotid-surgery success 2Health News:Global AIDS Alliance Welcomes Election of Barack Obama 2Health News:The Advisory Board Company Reports Fiscal Year 2009 Second Quarter Results 2Health News:The Advisory Board Company Reports Fiscal Year 2009 Second Quarter Results 3Health News:The Advisory Board Company Reports Fiscal Year 2009 Second Quarter Results 4Health News:The Advisory Board Company Reports Fiscal Year 2009 Second Quarter Results 5Health News:The Advisory Board Company Reports Fiscal Year 2009 Second Quarter Results 6Health News:The Advisory Board Company Reports Fiscal Year 2009 Second Quarter Results 7Health News:The Advisory Board Company Reports Fiscal Year 2009 Second Quarter Results 8Health News:The Advisory Board Company Reports Fiscal Year 2009 Second Quarter Results 9Health News:The Advisory Board Company Reports Fiscal Year 2009 Second Quarter Results 10
(Date:3/27/2015)... Holdings, Inc. (NYSE and SIX: ZMH) is celebrating a key milestone in ... Knee System. ,   ... introduced the NexGen knee system, with its innovative design and ... of the NexGen knee have taken place worldwide. ... the importance of design innovation and component quality for surgeons and patients ...
(Date:3/27/2015)... Quebec , March 27, 2015  Valeant Pharmaceuticals ... today the closing of its previously announced registered offering ... (the "Offering"). Pursuant to the Offering, the ... $199.00 per share, for aggregate gross proceeds of approximately ... with the U.S. Securities and Exchange Commission a final ...
(Date:3/27/2015)... , March 27, 2015  RXi ... privately-held MirImmune LLC, today announced that they ... to RXi,s novel and proprietary sd-rxRNA® technology ... immunotherapies. The collaboration has the potential to ... friendly cancer treatments that could be a ...
Breaking Medicine Technology:Zimmer Celebrates Key Milestones For NexGen Complete Knee System 2Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 2Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 3RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 2RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 3RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 4RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 5